International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 832

PDF Downloaded: 713


Get Permission Sharma and Pandit: Study of hs-CRP and insulin resistance in type 2 diabetic subjects


Introduction

Diabetes mellitus occurs due to insufficient or inefficient insulin leads to hyperglycaemia. The prevalence of type- 2 diabetes mellitus has been increasing day by day worldwide at this time.1 Macro and micro vascular complications in patients of type - 2 diabetes mellitus shows that it leads to heart disease, retinopathy, neuropathy and nephropathy etc.2

Insulin resistance is a condition in which the peripheral tissues of the human body shows resistance to the action of insulin, it is aggravated factors like type - 2 diabetes mellitus, obesity, hypertension etc. Insulin resistance is strongly related with the development of type- 2 diabetes. Therefore, it is necessary to identify the various risk factors for developing insulin resistance, so that preventive procedures can be developed.

Obesity also acts as a risk factor for various chronic diseases including type-2 diabetes and insulin resistance.3, 4 An increase in level of serum high-sensitivity C-reactive protein (hs-CRP) is broadly accepted as a significant risk factor for the development of cardiovascular disease (CVD) also.5, 6, 7

High sensitive C-reactive protein (an acute-phase reactant protein produced by liver) is an extreme sensitive marker for inflammation. It is found that chronic inflammation of low grade as revealed by increased level of hs-CRP might potentially be a cause underlying the etiology and manifestation of type- 2 diabetes.8, 9

hs-CRP, an acute phase protein produced primarily by liver cells under the influence of cytokines such as Tumor Necrosis Factor –α and Interleukin-6.10 Major features of T-2DM include insulin resistance, glucose intolerance, hyperinsulinemia, hyperglycemia, and dyslipidemia.11

The aim was to assess whether high sensitive-C Reactive Protein can be used as a biomarker to detect insulin resistance in type - 2 diabetes mellitus and healthy adults in Greater Gwalior region in India.

Materials and Methods

The study was carried out in Government Medial College, Shivpuri (MP). Subjects were selected from Department of Medicine of Medical College and those attending the medical outpatient camps at Shivpuri as well as Gwalior region of MP. The study included a total number of 200 subjects, diagnosis being based on duration of type-2diabetes mellitus. The patients were divided into two groups-

Group I: 100 Healthy individuals free from any diabetic complications and diabetes

Group II: 100 type- 2 Diabetic patients with complications (60men and 40 women).

The inclusion criteria for the selection of diabetic subjects was high blood sugar value – fasting > 126mg/dl and Post Prandial >200 mg/dl, duration of diabetes mellitus. The exclusion criteria- diabetic subjects having other complications, smokers, more alcohol intake etc.

A written consent was obtained from the patients. A questionnaire regarding the demographic data like age, sex, height (cm), body weight (kg) and duration of diabetes mellitus were measured while using light weight clothing but not shoes. Smoking habit, vegetarian and non-vegetarian, family history of diabetes mellitus, Blood pressure, hypertension, obesity, MI and renal disease were also noted for each patient. Approval for conducting this study was granted from the Institutional Ethical Committee of Government Medical College, Shivpuri (MP).

To evaluate the association between T-2DM and hs-CRP levels were used by Multivariate logistic regression models, both as continuous and discrete traits, with age, sex, height (cm), body weight in kg and BMI as covariates. hs-CRP levels were classified into three groups, low risk (<1 mg/liter), intermediate risk (1–3 mg/liter), and high risk (>3mg/liter), according to the AHA and CDC recommendations. All statistical values were analysed by using SPSS version 22.0. The P- values <0.001 were noted as the level of significance.

Fasting blood samples (venous) were collected from both study groups, the samples were centrifuged, serum was separated and kept at 4°C.

hs-CRP (by using a latex-immunoturbidimetric high sensitivity method based on the principle of agglutination reaction) were measured in the laboratory according to manufacturer’s protocol(POINTE SCIENTIFIC, INC.5449 RESEARCH DRIVE, CANTON, MI 48188). Plasma levels of fasting insulin were measured by using a sandwich ELISA kit method (LDN LABOR DIAGNOSTIKA NORD, ELISA Kit, GmbH & Co. KG) based on the sandwich principle). Estimation of serum glucose was done by Glucose Oxidase- Peroxidase (GOD -POD) method.

Lipid profile were determined according to manufacturer’s protocol such as Serum triglycerides by Tinder’s GPO-POD enzymatic method, Serum total cholesterol by Cholesterol Oxidase –Peroxidase enzymatic method and serum HDL by Phosphotungstic acid method. Serum LDL and VLDL values were calculated by Friedewald’s formula.

Result

The study was done on 100 patients of type-2 diabetes cases and 100 controls. The mean age of the patients was 52±8.24 years (Range- 35 to 75). Comparison of means of serum biochemical markers between type-2 diabetic group and healthy groups is presented in Table 1. The values of all these biochemical study parameters such as FBS, Glycosylated hemoglobin (HbA1c), TC, TG, VLDL, LDL, hs-CRP, Fasting plasma Insulin level and HOMA-IR except HDL were increased in diabetic cases as compared to healthy subjects and the observations were found to be statistically significant (P value <0.01 and <0.001).

The P value of 0.01 and 0.001 was found statistically significant. Simple (Pearson Correlation) correlation coefficients between hs-CRP and various parameters were calculated. We observed positively correlated with fasting glucose (0.684), HbA1c (0.612), total cholesterol (0.696), triglycerides (0.658), LDL (0.524), fasting insulin (0.386) and homeostasis model assessment of insulin resistance (HOMA-IR) (0.422) and negatively with HDL (-0.432) among groups.

Insulin resistance was calculated by using HOMA-IR calculator.

HOMA-IR = Fasting plasma insulin (μU/L) × fasting glucose (mg/dl) / 405

The diabetic group had significantly higher BMI, FBS, fasting insulin (17.32±2.10μU/ml vs 6.13±1.26μU/ml),HOMA-IR and hs-CRP (3.64 ± 1.38 mg/l vs 1.28 ± 0.68mg/l) than the healthy control group.

Figure 1

Hundred diagnosed type-2 diabetes mellitus patients age between 35-75 years were selected for this cross sectional study. Out of which 60 (60%) were males and 40 (40%) females

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/5028cc1a-b16c-4763-952b-201437f1c872/image/a877e8ee-4b11-4d0b-b16e-be8db1f20be2-uimage.png

Table 1

Comparison of physiological and biochemical parameters between study groups

Study Variables Healthy Controls=100 Type 2 Diabetic Subjects=100
Age (years) 48±8.80 52±8.24
Duration of diabetes (years) - 12.5±4.32
BMI (kg/m²) 21.42+ 1.56 27.62+ 3.68*
BP Systolic (mm/Hg) 106.6±4.18 166.85±3.89
BP Diastolic (mm/Hg) 78.6±1.28 110.85±4.85
FBS(mg/dl) 86.22±12.26 188.24±37.7**
HbA1c(%) 4.6±2.26 10.2±2.26**
Total Cholesterol (mg/dl) 158.3±24.09 252.4±41.9**
TG (mg/dl) 108.04±19.49 212.7±45.05*
HDL (mg/dl) 46.45±6.14 28.27±7.02
LDL (mg/dl) 110.1±16.20 158.7±39.3**
VLDL (mg/dl) 29.38±4.09 45.89±11.3
Fasting plasma Insulin(μU/ml) 6.14±1.24 16.42±2.12**
HOMA-IR 1.58 ± 0.88 6.50 ± 1.64
hs-CRP (mg/l) 1.28 ± 0.68 3.64 ± 1.38*

[i] * Significant at P<0.01, ** significant at P<0.001

Table 2

Pearson correlation studied of hs-CRP with the other biochemical parameters in Type-2 Diabetic groups

Biochemical Parameters r
FBS 0.684*
HbA1c 0.612*
Total Cholesterol 0.696*
Triglyceride 0.658*
LDL 0.524*
HDL -0.432*
Fasting plasma Insulin 0.386*
HOMA-IR 0.422*

[i] * Significant at P<0.001

Discussion

Our study showed Fasting Blood Glucose levels in type 2 diabetic group (mean 188.24±37.7) were higher than control group (mean 86.22±12.26). A significant difference was observed (p<0.001) in mean FBG level in Type-2 diabetic cases when compared with controls.

Glycosylat­ed haemoglobin (HbA1c) was also elevated in diabetic groups.12, 13, 14 The increased level of HbA1c is due to post-translational, spontaneous and nonenzymatic (Glycation) addition of glu­cose present in both outside and inside of the cells favouring attachment of glucose with each β-chain of HbA at N-terminal valine, resulting in progressive glycation end products (HbA1c).15 We also found that the average values of Total Cholesterol, Triglycerides, Low Density Lipoprotein and Very Low Density Lipoprotein were significantly increased whereas High Density Lipoprotein was also found decreased in type- 2 diabetic subjects as compared to healthy and the results were statistically significant. The Positive correlation coeffi­cient of Total Cholesterol, Triglycerides, Low Density Lipoprotein and Very Low Density Lipoprotein were observed with hs-CRP in type-2 diabetic patients.

Insulin resistance and Inflammation are commonly found to be associated with various chronic diseases as type-2 diabetes.16, 17, 18 Measurement of inflammatory markers might be helpful for the prediction of the vascular risk in Type-2 diabetes mellitus cases. Inflammation is related with pathogenesis of Type-2 diabetes mellitus. IR and hyperglycemia are also promoting inflammation by increased oxidative stress and that may link diabetes mellitus to the atherosclerosis development.19 Increased levels of hs-CRP commonly well-established risk factors of T2DM as well as IR, obesity and hypertension.20 Obesity and IR have been well known risk factors for the major health issues such as type -2 diabetes, dyslipidemia, hypertension and cardiovascular diseases etc. Central obesity is linked and played a main role in the development of IR and Type-2 diabetes mellitus.21 Increased levels of hs-CRP is responsible for the development of systemic inflammation as it is a well known risk factor for the development of Type-2 diabetes.9, 22, 23

Conclusion

The results showed that hs-CRP strongly related with type-2 diabetes patients and the metabolic variables of Type- 2 diabetes mellitus patients with and without complications in subjects. The hs-CRP may be considered as a predictor for the development of cardiovascular diseases, nephropathy, retinopathy and neuropathy in Type - 2 diabetic populations. Clinical study observations indicate the benefit of early insulin resistance treatment to oppose Type- 2 Diabetes in patients with raised level of hs-CRP.

Source of Funding

None.

Conflict of Interest

None.

References

1 

L. Guariguata D R Whiting I Hambleton J Beagley U Linnenkamp J E Shaw Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Res Clin Pract20141032137490168-8227Elsevier BV

2 

M J Fowler Microvascular and Macrovascular Complications of DiabetesClin Diabetes2011293116220891-8929, 1945-4953American Diabetes Association

3 

V Bermudez J Salazar M S Martoanez M Chaavez-Castillo L C Olivar M J Calvo Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, VenezuelaAdv Prev Med2016Venezuela

4 

D W Haslam W P James Effect of obesity on the incidence of type 2 diabetes mellitus varies with ageamong Indian womenLancet200536611971209

5 

Paul M. Ridker Mary Cushman Meir J. Stampfer Russell P. Tracy Charles H. Hennekens Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenN Engl J Med19973361497390028-4793, 1533-4406Massachusetts Medical Society

6 

Paul M. Ridker Nader Rifai Michael Clearfield John R. Downs Stephen E. Weis J. Shawn Miles Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary EventsN Engl J Med2001344261959650028-4793, 1533-4406Massachusetts Medical Society

7 

N. S. Rost P. A. Wolf C. S. Kase M. Kelly-Hayes H. Silbershatz J. M. Massaro Plasma Concentration of C-Reactive Protein and Risk of Ischemic Stroke and Transient Ischemic Attack: The Framingham StudyStroke20013211257590039-2499, 1524-4628Ovid Technologies (Wolters Kluwer Health)

8 

E S Ford The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination SurveyAtheroscler20031683518

9 

A D Pradhan J E Manson N Rifai J E Buring Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusJAMA28632734

10 

Reza Alizadeh Dehnavi Albert de Roos Ton J. Rabelink Johannes van Pelt Maarten J. Wensink Johannes A. Romijn Elevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesityAtheroscler2008200417230021-9150Elsevier BV

11 

Tom Seijkens Pascal Kusters David Engel Esther Lutgens CD40–CD40L: Linking pancreatic, adipose tissue and vascular inflammation in type 2 diabetes and its complicationsDiabetes Vasc Dis Res2013102115221479-1641, 1752-8984SAGE Publications

12 

J P Bastard Mustapha Maachi Claire Lagathu Min Ji Kim Martine Caron Recent advances in the relation­ship between obesity, inflammation, and insulin resist­ance EurCytokine Netw200617412

13 

M H S Al-Dhar E H Jiffery Increased adipose tissue expression of TNF-α and insulin resistance in obese subjects with type-2 DiabetesDiabetes201053050

14 

Matthew J. Sheetz Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic ComplicationsJAMA200228820257925790098-748410.1001/jama.288.20.2579American Medical Association (AMA)https://dx.doi.org/10.1001/jama.288.20.2579

15 

George Suji S. Sivakami Glucose, glycation and agingBiogerontol200456365731389-5729, 1573-6768Springer Science and Business Media LLC

16 

M K Piya P G McTernan S Kumar Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxinJ Endocrinol20132161T1T150022-0795, 1479-6805Bioscientifica

17 

D Sharma S K Singh P Gupta N Singh Role of Insulin Resistance in Non Alcoholic Fatty Liver in Obese Type-2 Diabetic SubjectsJ Med Sci Clin Res20142183843

18 

D Sharma S K Singh Status of Liver Enzymes in Non Alcoholic Fatty Liver in Obese Type-2 Diabetic SubjectsInt J Sci Res2014316523

19 

Samia Mora Kiran Musunuru Roger S Blumenthal The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice GuidelinesClin Chem2009552219280009-9147, 1530-8561Oxford University Press (OUP)

20 

J C Chambers S Eda P Bassett Y Karim S G Thompson J R Gallimore Kooner JS C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whitesCirc200110414550

21 

Nishan S. Kalupahana Naima Moustaid-Moussa Kate J. Claycombe Immunity as a link between obesity and insulin resistanceMol Aspects Med20123326360098-2997Elsevier BV

22 

A Pfutzner T Forst High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitusDiabetes Technol Ther2006812836

23 

D Sharma S K Singh N Singh R Kumar P Gautam Status of high sensitive C- reactive protein (hs-CRP) in Non Alcoholic Fatty Liver in Obese Type-2 Diabetic SubjectsInt J Clin Biochem Res201853



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

212-215


Authors Details

Dharmveer Sharma, Vidyanand Pandit


Article Metrics


View Article As

 


Downlaod Files